|
Volumn 36, Issue 5, 2009, Pages 297-299
|
The economic burden of pediculosis pubis and scabies infections treated on an outpatient basis in the united states: Evidence from private insurance claims data, 2001-2005
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IVERMECTIN;
LINDANE;
MALATHION;
PERMETHRIN;
PIPERONYL BUTOXIDE;
PYRETHRIN;
ARTICLE;
BILLING AND CLAIMS;
CLINICAL FEATURE;
COST OF ILLNESS;
HEALTH INSURANCE;
HUMAN;
INCIDENCE;
OUTCOME ASSESSMENT;
OUTPATIENT CARE;
PRESCRIPTION;
PUBIC PEDICULOSIS;
SCABIES;
UNITED STATES;
WORLD HEALTH ORGANIZATION;
ADOLESCENT;
ADULT;
ECONOMICS;
FEMALE;
MALE;
MIDDLE AGED;
OUTPATIENT;
PEDICULOSIS;
ADOLESCENT;
ADULT;
COST OF ILLNESS;
FEMALE;
HUMANS;
INCIDENCE;
LICE INFESTATIONS;
MALE;
MIDDLE AGED;
OUTPATIENTS;
SCABIES;
UNITED STATES;
|
EID: 67649950946
PISSN: 01485717
EISSN: None
Source Type: Journal
DOI: 10.1097/OLQ.0b013e31819241ef Document Type: Article |
Times cited : (18)
|
References (10)
|